| Wendy Ellen Handler, MD | |
|
7440 Spring Village Dr, Springfield, VA 22150-4446 | |
| (703) 923-4644 | |
| (703) 923-4625 |
| Full Name | Wendy Ellen Handler |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 7440 Spring Village Dr, Springfield, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578649927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101051060 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
Hyperbaric treatment for children with autism has reportedly led to improvements in the condition, though previous studies were uncontrolled.
Idera Pharmaceuticals, Inc. today announced that it has chosen to delay initiating its planned Phase 2 clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase 2 clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naïve, genotype 1 hepatitis C virus (HCV) patients.
Case Western Reserve University's synchrotron facility at Brookhaven National Laboratory is on its way to becoming the No. 1 beamline facility for biology in the world by early 2016, thanks to a jumpstart grant of $4.6 million from the National Institute of Biomedical Imaging and Bioengineering, a component of the National Institutes of Health.
Researchers at the University of Copenhagen have documented a previously unknown biological mechanism in the brain's most important line of defence: the blood-brain barrier. Scientists now know that the barrier helps maintain a delicate balance of glutamate, a vital signal compound in the brain.
Sleep-related deaths are the most common cause of death for infants 1-12 months of age. The American Academy of Pediatrics recommends that infants sleep on their back on a firm mattress, without loose bedding. However, many parents use sitting or carrying devices, such as car seats, swings, or bouncers, as alternative sleeping environments, which could lead to potential injury or death.
› Verified 6 days ago
| Entity Name | Mgmc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891797148 PECOS PAC ID: 9537073119 Enrollment ID: O20031220000056 |
News Archive
Hyperbaric treatment for children with autism has reportedly led to improvements in the condition, though previous studies were uncontrolled.
Idera Pharmaceuticals, Inc. today announced that it has chosen to delay initiating its planned Phase 2 clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase 2 clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naïve, genotype 1 hepatitis C virus (HCV) patients.
Case Western Reserve University's synchrotron facility at Brookhaven National Laboratory is on its way to becoming the No. 1 beamline facility for biology in the world by early 2016, thanks to a jumpstart grant of $4.6 million from the National Institute of Biomedical Imaging and Bioengineering, a component of the National Institutes of Health.
Researchers at the University of Copenhagen have documented a previously unknown biological mechanism in the brain's most important line of defence: the blood-brain barrier. Scientists now know that the barrier helps maintain a delicate balance of glutamate, a vital signal compound in the brain.
Sleep-related deaths are the most common cause of death for infants 1-12 months of age. The American Academy of Pediatrics recommends that infants sleep on their back on a firm mattress, without loose bedding. However, many parents use sitting or carrying devices, such as car seats, swings, or bouncers, as alternative sleeping environments, which could lead to potential injury or death.
› Verified 6 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275886418 PECOS PAC ID: 2466351093 Enrollment ID: O20121219000193 |
News Archive
Hyperbaric treatment for children with autism has reportedly led to improvements in the condition, though previous studies were uncontrolled.
Idera Pharmaceuticals, Inc. today announced that it has chosen to delay initiating its planned Phase 2 clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase 2 clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naïve, genotype 1 hepatitis C virus (HCV) patients.
Case Western Reserve University's synchrotron facility at Brookhaven National Laboratory is on its way to becoming the No. 1 beamline facility for biology in the world by early 2016, thanks to a jumpstart grant of $4.6 million from the National Institute of Biomedical Imaging and Bioengineering, a component of the National Institutes of Health.
Researchers at the University of Copenhagen have documented a previously unknown biological mechanism in the brain's most important line of defence: the blood-brain barrier. Scientists now know that the barrier helps maintain a delicate balance of glutamate, a vital signal compound in the brain.
Sleep-related deaths are the most common cause of death for infants 1-12 months of age. The American Academy of Pediatrics recommends that infants sleep on their back on a firm mattress, without loose bedding. However, many parents use sitting or carrying devices, such as car seats, swings, or bouncers, as alternative sleeping environments, which could lead to potential injury or death.
› Verified 6 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000415 |
News Archive
Hyperbaric treatment for children with autism has reportedly led to improvements in the condition, though previous studies were uncontrolled.
Idera Pharmaceuticals, Inc. today announced that it has chosen to delay initiating its planned Phase 2 clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase 2 clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naïve, genotype 1 hepatitis C virus (HCV) patients.
Case Western Reserve University's synchrotron facility at Brookhaven National Laboratory is on its way to becoming the No. 1 beamline facility for biology in the world by early 2016, thanks to a jumpstart grant of $4.6 million from the National Institute of Biomedical Imaging and Bioengineering, a component of the National Institutes of Health.
Researchers at the University of Copenhagen have documented a previously unknown biological mechanism in the brain's most important line of defence: the blood-brain barrier. Scientists now know that the barrier helps maintain a delicate balance of glutamate, a vital signal compound in the brain.
Sleep-related deaths are the most common cause of death for infants 1-12 months of age. The American Academy of Pediatrics recommends that infants sleep on their back on a firm mattress, without loose bedding. However, many parents use sitting or carrying devices, such as car seats, swings, or bouncers, as alternative sleeping environments, which could lead to potential injury or death.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendy Ellen Handler, MD 5525 Research Park Dr, 4th Floor, Baltimore, MD 21228-4873 Ph: (410) 402-2258 | Wendy Ellen Handler, MD 7440 Spring Village Dr, Springfield, VA 22150-4446 Ph: (703) 923-4644 |
News Archive
Hyperbaric treatment for children with autism has reportedly led to improvements in the condition, though previous studies were uncontrolled.
Idera Pharmaceuticals, Inc. today announced that it has chosen to delay initiating its planned Phase 2 clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase 2 clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naïve, genotype 1 hepatitis C virus (HCV) patients.
Case Western Reserve University's synchrotron facility at Brookhaven National Laboratory is on its way to becoming the No. 1 beamline facility for biology in the world by early 2016, thanks to a jumpstart grant of $4.6 million from the National Institute of Biomedical Imaging and Bioengineering, a component of the National Institutes of Health.
Researchers at the University of Copenhagen have documented a previously unknown biological mechanism in the brain's most important line of defence: the blood-brain barrier. Scientists now know that the barrier helps maintain a delicate balance of glutamate, a vital signal compound in the brain.
Sleep-related deaths are the most common cause of death for infants 1-12 months of age. The American Academy of Pediatrics recommends that infants sleep on their back on a firm mattress, without loose bedding. However, many parents use sitting or carrying devices, such as car seats, swings, or bouncers, as alternative sleeping environments, which could lead to potential injury or death.
› Verified 6 days ago
Meredith Lynn Porter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6230 Rolling Rd Ste J, Springfield, VA 22152 Phone: 571-665-6460 Fax: 571-665-6461 | |
Dr. Sonya Nadine Bethel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7440 Spring Village Dr, Springfield, VA 22150 Phone: 703-923-4644 Fax: 703-923-4625 | |
Dr. Sally R Hayes, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 6230 Rolling Rd Ste Iandj, Springfield, VA 22152 Phone: 571-665-6460 Fax: 571-565-6561 | |
Jeffrey K Nekoba, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7489 Huntsman Blvd, Springfield, VA 22153 Phone: 571-642-1460 Fax: 703-440-1203 | |
Dr. Farah Saeed, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6501 Loisdale Ct, Kaiser Permanente Springfield Medical Center, Springfield, VA 22150 Phone: 703-922-1000 | |
Dr. Priya Jagannathan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6501 Loisdale Ct, Springfield, VA 22150 Phone: 703-944-7662 | |
Mrs. Rebecca Mensah, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8020 Pohick Rd, Springfield, VA 22153 Phone: 571-484-0443 |